UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://epims.med.ubc.ca" title="UBC PiMS Research Group (the Tremlett Laboratory)" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/research/" title="Research">Research</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/research/presentations/" title="Conference Presentations">Conference Presentations</a> <span class="sep">»</span> International Conference on Pharmacoepidemiology & Therapeutic Risk Management [ICPE All Access 2020] </div></div>

International Conference on Pharmacoepidemiology & Therapeutic Risk Management [ICPE All Access 2020]

Huah Shin Ng:

Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: a population-based study

Poster

 

Safety profile of ocrelizumab for the treatment of multiple sclerosis: a systematic review

Poster

Last updated on November 27, 2020 @7:25 pm

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia